<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04489342</url>
  </required_header>
  <id_info>
    <org_study_id>WesternHSCT</org_study_id>
    <nct_id>NCT04489342</nct_id>
  </id_info>
  <brief_title>Advanced Sensor Based Functional ASsessmenTs in Axial Spondyloarthritis</brief_title>
  <acronym>ASFASTAS</acronym>
  <official_title>An Investigation Into the Responsiveness of Inertial Measurement Unit (IMU) Sensor-based Tests in Measuring Changes in Spinal Mobility and Function in Axial Spondyloarthritis Patients Treated With Biologic Drug</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Western Health and Social Care Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Ulster</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Western Health and Social Care Trust</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an observational study using IMU sensors to measure the effects of biological therapy
      on spinal mobility and function in axial spondyloarthritis. Participants will undergo MRI
      scans before and after therapy in parallel to the sensor tests to establish correlation
      between changes in inflammatory signs and changes in spinal mobility.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We will study 20 participants with active axSpA who are about to start biologic therapy as
      part of routine care. In brief, we will carry out the following assessments before and after
      therapy:

        1. MRI of spine and SI joints - mSASSS scoring

        2. Record standard PROs: BASDAI, BASG, BASMI, BASFI, ASDAS, ASAS-HI, EQ5D-3L, WPAI, SQUASH,

        3. ESR, CRP

        4. IMU sensor tests in clinic for ROM in cervical, thoracic and lumbar spine.

        5. IMU sensor tests at home for standardised function testing
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 1, 2019</start_date>
  <completion_date type="Anticipated">February 7, 2022</completion_date>
  <primary_completion_date type="Anticipated">January 7, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in IMU-ASMI</measure>
    <time_frame>4 months</time_frame>
    <description>Change in AxSpA metrology index based on sensor tests of Range of Movement (i.e. spinal mobility)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in BASMI</measure>
    <time_frame>4 months</time_frame>
    <description>Change in traditional metrology index of spinal mobility</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in BASDAI</measure>
    <time_frame>4 months</time_frame>
    <description>Change in axSpA disease activity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in ASAS response</measure>
    <time_frame>4 months</time_frame>
    <description>Change in axSpA disease activity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in mSASSS</measure>
    <time_frame>4 months</time_frame>
    <description>Change in MRI score of inflammation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in BASFI</measure>
    <time_frame>4 months</time_frame>
    <description>Change in traditional questionnaire function assessment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Standardised Functional Test Scores</measure>
    <time_frame>4 months</time_frame>
    <description>Change in composite SFT score</description>
  </secondary_outcome>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Axial Spondyloarthritis</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ViMove IMU sensor test</intervention_name>
    <description>Measurement of maximum range of movement in the spine; Ambulatory observational data while performing standardised functional tests</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with active axSpA (BASDAI &gt;4, Spinal Pain VAS &gt;4)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Diagnosis of axial spondyloarthritis fulfilling ASAS classification criteria.

          2. Age â‰¥18 years old and &lt;80 years.

          3. Fulfilment of local criteria for biologic therapy for axSpA.

          4. The subjects should be able to read, write, understand and complete study
             questionnaires.

          5. Each subject must sign an informed consent form (ICF) indicating that he or she
             understands the purpose of and procedures required for the study and are willing to
             participate in the study.

        Exclusion Criteria:

        EC1. Safety contra-indication for biologic drug therapy. EC2. Severely restricted hip
        movement (less than 20 degrees rotation in either hip).

        EC3. History of previous clinical (symptomatic) vertebral fracture. EC4. History of
        previous spinal surgery. EC5. History of previous hip replacement surgery. EC6. Major
        scoliosis deformity (in the opinion of the investigator). EC7. Safety contra-indication for
        MRI assessment. EC8. Previous biologic agent within 2 months. EC9. Pregnant or
        breast-feeding women.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Department of Rheumatology, Altnagelvin Hospital</name>
      <address>
        <city>Londonderry</city>
        <state>N.Ireland</state>
        <zip>BT47 6SB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philip V Gardiner, MD FRCP</last_name>
      <phone>02871345171</phone>
      <phone_ext>213618</phone_ext>
      <email>philip.gardiner@westerntrust.hscni.net</email>
    </contact>
    <investigator>
      <last_name>Philip V Gardiner, MB BCh MD FRCP</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>July 24, 2020</study_first_submitted>
  <study_first_submitted_qc>July 24, 2020</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 28, 2020</study_first_posted>
  <last_update_submitted>July 24, 2020</last_update_submitted>
  <last_update_submitted_qc>July 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Western Health and Social Care Trust</investigator_affiliation>
    <investigator_full_name>Dr Philip Gardiner</investigator_full_name>
    <investigator_title>Consultant Rheumatologist</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spondylarthritis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Willing to share details of results and analyses with other researchers</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

